Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;19(4):431-4.
doi: 10.1007/s10552-007-9102-9. Epub 2007 Dec 18.

Cancer screening in France: subjects' and physicians' attitudes

François Eisinger  1 , Jean-Yves Blay, Jean-François Morère, Olivier Rixe, Anne Calazel-Benque, Laurent Cals, Yvan Coscas, Sylvie Dolbeault, Moïse Namer, Daniel Serin, Claire Roussel, Xavier Pivot; EDIFICE Committee
Affiliations

Cancer screening in France: subjects' and physicians' attitudes

François Eisinger et al. Cancer Causes Control. 2008 May.

Abstract

Objective: Since screening for cancer has been advocated, funded, and promoted in France, it is important to evaluate the attitudes of subjects in the general population and general practitioners (GPs) toward cancer screening strategies.

Methods: EDIFICE is a nationwide opinion poll that was carried out by telephone among a representative sample of 1,504 subjects living in France and aged between 40 and 75 years and among a representative sample of 600 GPs. The questionnaire administered to subjects queried about previous screening for cancer.

Results: Ninety-three percent of women stated that they had undergone at least one mammography. Although rated "A" recommendation-strongly recommended-by the US Preventive Services Task Force, screening for colorectal cancer received less attention than prostate cancer screening which is rated "I"-insufficient evidence-(reported screening rates of 25% and 36%, respectively). Six percent of subjects stated that they had undergone lung cancer screening. GPs' attitudes toward cancer screening showed similar inconsistencies.

Conclusions: It thus appears that understanding of cancer screening practices in the French general population does not match scientific evidence. To a lesser extent, this also holds for GPs.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Adherence to cancer screening strategies according to the French nationwide EDIFICE opinion poll (1,504 subjects, 600 general practitioners). In France, there are organized mass-screening programs for breast cancer by mammography (100% of the population covered at the time of the opinion poll) and for colorectal cancer using Hemoccult (almost 30% of the population covered). In contrast, there is no mass-screening program for prostate cancer and lung cancer. For subjects in the general population, figures indicate the rates of subjects stating that they had undergone at least one screening test. For general practitioners, figures indicate the rates of general practitioners stating that they systematically recommended cancer screening
See this image and copyright information in PMC

References

    1. Gotzsche PC, Nielsen M (2006) Screening for breast cancer with mammography. Cochrane Database Syst Rev CD001877 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12118972', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12118972/'}]}
    2. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN (2002) Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137:132–141 - PubMed
    1. U.S. Preventive Services Task Force (2006) The guide to Clinical Preventive Services 2006: Agency for Healthcare Research and Quality
    1. Institut National des Statistiques et des Etudes Economiques (INSEE) (2002) Enquête emploi, Mars 2002. “Société” résultats détaillés no. 5
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(03)12890-5', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(03)12890-5'}, {'type': 'PubMed', 'value': '12672328', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12672328/'}]}
    2. Frankel S, Smith GD, Donovan J, Neal D (2003) Screening for prostate cancer. Lancet 361:1122–1128 - PubMed

Publication types